SCHEMBL22839372

SCHEMBL22839372

CCCCCCCCCCCCC(CC)NCc1cncnc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23718420 0.71 TDP1 (0.38) —
SCHEMBL23718261 0.69 HRH3 (0.37) —
SCHEMBL23571237 0.69 CYP11B1 (0.33) —
SCHEMBL23571253 0.69 CYP11B1 (0.33) —
SCHEMBL21361275 0.68 GPR84 (0.35) —
SCHEMBL25587990 0.68 MIF (0.38) —
SCHEMBL25620575 0.68 NR3C1 (0.42) —
SCHEMBL11728106 0.68 LIPG (0.34) —
SCHEMBL20794423 0.66 TLR2 (0.49) —
SCHEMBL18844905 0.66 TLR2 (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524608-B1 NOVEL PYRIMIDINE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION USING SAME SPARK BIOPHARMA INC (KR) 2020-12-30 — — EP disclosed
Send feedback